An Investigational Immuno-therapy Study to Test Combination Treatments in Patients With Advanced Non-Small Cell Lung Cancer

PHASE2TerminatedINTERVENTIONAL
Enrollment

295

Participants

Timeline

Start Date

May 9, 2016

Primary Completion Date

January 29, 2020

Study Completion Date

January 29, 2020

Conditions
Advanced Cancer
Interventions
BIOLOGICAL

Nivolumab

Arm associated with this intervention is closed. Nivolumab is no longer given as an active comparator.

DRUG

Dasatinib

BIOLOGICAL

Relatlimab

BIOLOGICAL

Ipilimumab

DRUG

BMS-986205

Specified dose on specified days

Trial Locations (50)

5020

Local Institution, Salzburg

10065

Memorial Sloan Kettering Cancer Center, New York

14263

Roswell Park Cancer Institute, Buffalo

15217

University of Pittsburgh Medical Center, Pittsburgh

19107

Thomas Jefferson University, Philadelphia

20089

Local Institution, Rozzano

20132

Local Institution, Milan

20141

Local Institution, Milan

21201

University of Maryland - Marlene and Stewart Greenebaum Cancer Center, Baltimore

21287

Sidney Kimmel Comprehensive Cancer Center, Baltimore

22031

Virginia Cancer Specialists, PC, Fairfax

27514

Univ of NC Shool of Medicine, Chapel Hill

28041

Local Institution, Madrid

28050

Local Institution, Madrid

31008

Local Institution, Pamplona

31059

Local Institution, Toulouse

37203

Sarah Cannon Cancer Center, Nashville

38138

The West Clinic, P.C. d/b/a West Cancer Center, Germantown

43210

The Ohio State University, Columbus

48109

University of Michigan Health System (UMHS) - University Hospital (University of Michigan Medical Ce, Ann Arbor

48201

Karmanos Cancer Institute, Detroit

63110

Washington University, The Center for Advanced Medicine, St Louis

66205

University of Kansas Cancer Center, Westwood

75005

Local Institution, Paris

75246

Sammons Cancer Center (Uso), Dallas

75702

Us Oncology, Tyler

76104

Texas Oncology, P.A., Fort Worth

77030

The University of Texas MD Anderson Cancer Center, Houston

80045

University of Colorado Denver, Aurora

84112

Huntsman Cancer Institute, Salt Lake City

89119

Comprehensive Cancer Centers of Nevada, Las Vegas

90033

University of Southern California (USC), Los Angeles

90048

Cedars-Sinai Medical Center, Los Angeles

90095

University of Californa, Los Angeles (UCLA), Los Angeles

91010

City of Hope National Medical Center, Duarte

92122

University of California San Diego, San Diego

92658

Hoag Memorial Hospital Presbyterian, Newport Beach

94805

Local Institution, Villejuif

97225

Northwest Cancer Specialists, Portland

98109

University of Washington-Seattle Cancer Care Alliance, Seattle

06511

Yale Cancer Center, New Haven

02114

Massachusetts General Hospital, Boston

02215

Beth Israel Deaconess Medical Center, Boston

Dana Farber/Harvard Cancer Center, Boston

19111-2497

Fox Chase Cancer Center, Philadelphia

Unknown

Local Institution, Clayton

L8V 5C2

Juravinski Cancer Centre, Hamilton Health Sciences-Mcmaster Univeristy's Faculty Of Health Sciences, Hamilton

K1H 8L6

University Of Ottawa - The Ottawa Hospital Cancer centre, Ottawa

T6G 1Z2

Local Institution, Edmonton

CH-1011

Local Institution, Lausanne

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY